Driving performance under antidepressants - Do selective serotinin re- uptake inhibitors impair driving performance less than tricyclic antidepressants?;Fahrtauglichkeit unter antidepressiva - Beeintrachtigen selektive serotonin-wiederaufnahmehemmer die fahrtauglichkeit geringer als trizyklische antidepressiva?

Psychopharmakotherapie

Volumn 6, Issue 1, 1999, Pages 2-7

  Gartenmaier, Andreas ^a   Schäfer, Martin ^a   Soyka, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Depression; Driving performance; Psychomotor performance; Selective serotonin reuptake inhibitors; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; FLUOXETINE; FLUVOXAMINE; MIANSERIN; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; COGNITION; DEPRESSION; DRIVING ABILITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR DISORDER; PSYCHOMOTOR PERFORMANCE;

EID: 2442765379     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Berghaus G, Friedel B. Entwicklung von Standards für die Untersuchung medikamentenbedingter Beeinträchtigungen der Fahrsicherheit - Aktueller Stand und Forschungsbedarf. In: Krüger HP, Kohnen R, Schöch H, Hrsg. Medikamente im Straßenverkehr. Stuttgart: Gustav Fischer Verlag, 1995:61-8.
2. Crome P, Newman B. A comparison of the effects of single doses of mianserin and amitriptyline on psychomotor tests in normal volunteers. J Int Med Res 1978;6:430-4.
3. Curran HV, Lader M. The psychopharmacological effects of repeated doses of fluvoxamin, mianserin and placebo in healthy human subjects. Eur J Clin Pharmacol 1986;29:601-7.
4. Edwards JG. Drug choice in depression - Selective serotonin reuptake inhibitors or tricyclic antidepressants? CNS Drugs 1995;4:141-59.
5. Edwards JG, Imman WHW, Wilton L, Pearce GL. Prescription-event monitoring of 10401 patients treated with fluvoxamine. Br J Psychiatry 1994;164:387-95.
6. Fairweather DB, Kerr JS, Harrison DA, Moon CA, et al. A double blind comparison of fluoxetine and amitriptyline on cognitive function in elderly depressed patients. Hum Psychopharmacol 1993;8:41-7.
7. Friedel B, Lappe E. Neue Begutachtungs-Leitlinien "Krankheit und Kraftverkehr" - was bringen sie Neues? Med Sach 1996;92/5:144-8.
8. Grabe HJ, Wolf T, Grätz S, Laux G. The influence of polypharmacological antidepressive treatment on central nervous information processing of depressed patients: implications for fitness to drive. Neuropsychobiology 1998;37: 200-4.
9. Hale AS, Pinninti NR. Critical flicker fusion threshold and anticholinergic effects of chronic antidepressant treatment in remitted depressives. J Psychopharmacol 1995;9/3:258-66.
10. van Harten J, Stevens LA, Raghoeber M, Holland RL, et al. Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function. Clin Pharmacol Ther 1992;52:427-35.
11. Herberg KW. Antidepressiva und Verkehrssicherheit. Fortschr Neurol Psychiat 1994; 62(Sonderheft 1):24-8.
12. Herberg KW, Nickelsen T. Einflüsse von Fluoxetin mit und ohne gleichzeitige Gabe von Alkohol auf sicherheitsbedeutsame Leistungen. Studie zur Frage der Verkehrssicherheit bei antidepressiver Therapie. Kassenarzt 1992;32: 38-44.
13. Hindmarch I. Three antidepressants (amitriptyline, dothiepin, fluoxetine) with and without alcohol, compared with placebo on tests of psychomotor ability related to car driving. Hum Psychopharmacol 1987;2:177-83.
14. Hindmarch I. The behavioural toxicity of the selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 1995;9/Suppl 4:13-7.
15. Hindmarch I, Alford C, Barwell F, Kerr JS. Measuring the side effects of psychotropics: the behavioural toxicity of antidepressants. J Psychopharmacol 1992;6/2:198-203.
16. Hindmarch I, Bhatti JZ. Psychopharmacological effects of sertraline in normal, healthy volunteers. Eur J Clin Pharmacol 1988;35: 221-3.
17. Hindmarch I, Harrison C. The effects of paroxetine and other antidepressants in combination with alcohol, in psychomotor activity related to car driving. Hum Psychopharmacol 1988;3:13-20.
18. Irving A, Jones W. Methods for testing impairment of driving due to drugs. Eur J Clin Pharmacol 1992;43:61-6.
19. Kerr JS, Hindmarch I, Sherwood N. Correlation between doses of oxazepam and their effects on performance of a standardised test battery. Eur J Clin Pharmacol 1992;42:507-10.
20. Laux G. Psychomotorische Leistungsparameter und deren Beeinflussung während der Langzeittherapie unter besonderer Berücksichtigung von Fahrtauglichkeitsaspekten. In: Möller HJ, Staab HJ, Hrsg. Langzeitbehandlung mit Psychopharmaka. Stuttgart: Thieme Verlag, 1995:56-71.
21. Linnoila M. Psychotropic medications and traffic safety. J Clin Psychopharmacol 1992; 12/6:384-5.
22. Louwerens JW, Brookhuis KA, O'Hanlon JF. Several antidepressants' acute effects upon actual driving performance and subjective mental activation. In: O'Hanlon JF, de Gier JJ, Hrsg. Drugs and driving. Philadelphia: Taylor and Francis, 1986:203-13.
23. Metzner JL, Dentino AN, Godard SL, Hay DP, et al. Impairmant in driving and psychiatric illness. J Neuropsychiatry Clin Neurosci 1993; 5/2:211-20.
24. O'Hanlon JF. Antidepressant therapy and behavioural competence. BJCP 1996;50/7:381-5.
25. O'Hanlon JF, Brookhuis KA, Louwerens JW, Volkerts ER. Performance testing as part of drug registration. In: O'Hanlon JF, de Gier JJ, Hrsg. Drugs and driving. Philadelphia: Taylor and Francis, 1986:311-30.
26. O'Hanlon JF, Freeman H. Categorising the behavioural toxicities of antidepressants - proposals and requirements. Br J Psychiatry 1995; 166:421-3.
27. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992;136:873-83.
28. Robbe HWJ, O'Hanlon JF. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Neuropsychopharmacol 1995;5:35-42.
29. Saarialho-Kere U, Mattila MJ, Seppälä T. Parenteral pentazocine: Effects on psychomotor skills and respiration, and interaction with amitriptyline. Eur J Clin Pharmacol 1988;35:483-9.
30. Volz HP, Sturm Y. Antidepressant drugs and psychomotor performance. Neuropsychobiology 1995;31:146-55.
31. Willumeit HP, Ott H, Neubert W. Simulated car driving as a useful technique for the determination of residual effects and alcohol interaction after short-and long-acting benzodiazepines. Psychopharmacology 1984;Suppl 1:182-92.